Second, there are real implications on treatment. It's even more rare when it's accompanied by this low platelet condition. We're talking about a very rare and very serious blood clot in the brain. First, we're not talking about the run-of-the-mill blood clot here.
Wen: I think the FDA and CDC made the right decision. After all, it's six cases, out of nearly 7 million people who have received the Johnson & Johnson vaccine, and it's not clear that the vaccine caused the clot. This is being done out of an abundance of caution to allow time for a more thorough investigation.ĬNN: Some people have said this is an overreaction. This is expected to be temporary, hence the word "pause." Note that the federal officials have not said that the vaccine is no longer authorized or is being recalled. Patients currently scheduled for the Johnson & Johnson vaccine are probably going to receive another vaccine instead. In the meantime, they are asking mass vaccination sites, pharmacies and doctors' offices to hold off on giving this vaccine. The pause is to say there is a possible safety concern, and the FDA and CDC want time to investigate the concern. Leana Wen: The federal health authorities were very specific that this is a recommendation for a pause, not a requirement to stop the Johnson & Johnson vaccine rollout. Temporarily halting the use of the J&J vaccine shows that the protocols to keep people safe are in place, said Wen, an emergency physician and visiting professor of health policy and management at the George Washington University Milken Institute School of Public Health.ĬNN: First of all, what is a pause? What's going to happen to patients who are currently scheduled to get the vaccine?ĭr.
GETTING DOCTORS DIAGNOSTIC NOTES OUT OF EFILM LITE TRIAL
Leana Wen, author of the forthcoming book "Lifelines: A Doctor's Journey in the Fight for Public Health," who herself received the Johnson & Johnson vaccine as a volunteer participant in a clinical trial two weeks ago. What does all of this mean for people who have received the Johnson & Johnson vaccine? What about those who are scheduled to receive it? And should people be worried about the safety of Covid-19 vaccines, or actually reassured that regulatory authorities are doing their job? The agencies cited the cases of six women between the ages of 18 and 48 who had developed a rare and severe condition called cerebral venous sinus thrombosis (CVST), a brain blood clot, combined with thrombocytopenia, or low platelet counts, after their J&J vaccination. The US Food and Drug Administration and the Centers for Disease Control and Prevention said Tuesday that they were recommending a pause in the use of the Johnson & Johnson Covid-19 vaccine.
0 kommentar(er)
